Loading...
Loading...
Shares of Medivation
MDVN are lower on the session by 3.35%, currently trading at $45.53. The stock has been moving largely higher over the past three months and is currently trading above the 50-day moving average.
Options traders are focusing on puts today. The strike seeing the heaviest action is the January 2012 $35.00 put, which has traded 1,000 times on open interest of 1,536 contracts.
Put volume is outpacing call volume by 111 to 1.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of small molecule drugs to treat serious diseases, for which there are limited treatment options.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in